TEVA: 梯瓦制药
今日TEVA汇率已更改-0.76%。当日,交易品种以低点36.13和高点36.93进行交易。
关注梯瓦制药动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TEVA新闻
- Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study - Slideshow (NYSE:TEVA) 2026-09-04
- TEVA's TEV '408 Meets Goal in Phase IIa Celiac Disease Study
- Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript
- Teva Reports Significant Prevention Of Gluten-Induced Damage in New Study - Teva Pharmaceutical Indus (NY
- Teva Stock Rises After TEV '408 Meets Primary Endpoint in Celiac Disease Study - Teva Pharmaceutical Indu
- J&J Faces Multiple Headwinds: Can the Healthcare Giant Sustain Growth?
- Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
- Trump Expands Drug Pricing Agreements With 9 Drugmakers— RFK Jr. Says President Called ‘Every Hour’ to En
- Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid
- BioXcel Stock Plunges: Chapter 11 Filing Triggers Teva Stalking Horse Bid - Teva Pharmaceutical Indus (NY
- NBIX vs. TEVA: Which Drugmaker Is the Better Investment?
- TEVA's Ecopipam Wins FDA Priority Tag in Pediatric Tourette Syndrome
- Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises
- Neurocrine's Ingrezza Sales Keep Growing: Can the Momentum Last?
- Can NBIX's Q2 Beat and Higher Ingrezza Guidance Drive More Growth?
- Is NBIX Stock a Buy as Fast Growth Meets a Premium Sales Valuation?
- Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug - Aurinia Pharmaceuticals
- TEVA Stock Climbs as 50-Year-Long Tourette Syndrome Drug Breakthrough Moves Closer - TipRanks.com
- Teva Rises 17% YTD: Should You Buy, Sell or Hold the Stock?
- NBIX Stock Dips 12% in a Month: Time to Buy, Hold or Sell?
- Can Amneal's Kashiv Deal Turn Biosimilars Into a Major Growth Engine?
常见问题解答
TEVA股票今天的价格是多少?
梯瓦制药股票今天的定价为36.33。它在36.13 - 36.93范围内交易,昨天的收盘价为36.61,交易量达到4152。TEVA的实时价格图表显示了这些更新。
梯瓦制药股票是否支付股息?
梯瓦制药目前的价值为36.33。股息政策取决于公司,而投资者也会关注90.16%和USD。实时查看图表以跟踪TEVA走势。
如何购买TEVA股票?
您可以以36.33的当前价格购买梯瓦制药股票。订单通常设置在36.33或36.63附近,而4152和-0.16%显示市场活动。立即关注TEVA的实时图表更新。
如何投资TEVA股票?
投资梯瓦制药需要考虑年度范围19.01 - 38.37和当前价格36.33。许多人在以36.33或36.63下订单之前,会比较-0.36%和。实时查看TEVA价格图表,了解每日变化。
梯瓦制药股票的最高价格是多少?
在过去一年中,梯瓦制药的最高价格是38.37。在19.01 - 38.37内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪梯瓦制药的绩效。
梯瓦制药股票的最低价格是多少?
梯瓦制药(TEVA)的最低价格为19.01。将其与当前的36.33和19.01 - 38.37进行比较,可以发现潜在的长期切入点。观看TEVA在图表上的实时走势以获取更多详细信息。
TEVA股票是什么时候拆分的?
梯瓦制药历史上曾经历过股票拆分。这些变化在公司行动后的、36.61和90.16%中可见。
- 前一天收盘价
- 36.61
- 开盘价
- 36.39
- 卖价
- 36.33
- 买价
- 36.63
- 最低价
- 36.13
- 最高价
- 36.93
- 交易量
- 4.152 K
- 日变化
- -0.76%
- 月变化
- -0.36%
- 6个月变化
- 19.13%
- 年变化
- 90.16%